CAS RN 4291-63-8
CAS RN 4291-63-8
Cladribine, TRC
CAS: 4291-63-8 Molecular Formula: C10 H12 Cl N5 O3 Molecular Weight (g/mol): 285.69 Synonym: Cladribine,2-Chloro-9-(2-deoxy-β-d-erythro-pentofuranosyl)-9H-purin-6-amine,Adenosine, 2-chloro-2'-deoxy-,2-Chloro-2'-deoxyadenosine,(2R,3S,5R)-5-(6-Amino-2-chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol,2-CdA,2-Chloro-2'-deoxy-β-adenosine,2-Chloro-6-amino-9-(2-deoxy-β-D-erythro-pentofuranosyl)purine,2-Chlorodeoxyadenosine,Biodribin,Cladarabine,CldAdo,Jk 6251,Leustat,Leustatin,NSC 105014,NSC 105014-F,RWJ 26251 IUPAC Name: (2R,3S,5R)-5-(6-amino-2-chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol SMILES: Nc1nc(Cl)nc2c1ncn2[C@H]3C[C@H](O)[C@@H](CO)O3
Cladribine, Mikromol™
Discover Mikromol - your trusted source for high-quality pharmaceutical reference standards. Supporting accurate, compliant analysis with ISO 17034-accredited materials designed for confidence in every result.
MedChemExpress Cladribine
MedChemExpress Cladribine (2-Chloro-2′-deoxyadenosine), a purine nucleoside analog, is an orally active adenosine deaminase inhibitor. Cladribine functions as an inhibitor of DNA synthesis to block the repair of the damaged DNA. Cladribine can inhibit DNA methylation. Cladribine has anti-lymphoma activity. Cladribine can be used for the research of several hematologic malignancies and multiple sclerosis.
MedChemExpress Cladribine
MedChemExpress Cladribine (2-Chloro-2′-deoxyadenosine), a purine nucleoside analog, is an orally active adenosine deaminase inhibitor. Cladribine functions as an inhibitor of DNA synthesis to block the repair of the damaged DNA. Cladribine can inhibit DNA methylation. Cladribine has anti-lymphoma activity. Cladribine can be used for the research of several hematologic malignancies and multiple sclerosis.
MedChemExpress Cladribine
MedChemExpress Cladribine (2-Chloro-2′-deoxyadenosine), a purine nucleoside analog, is an orally active adenosine deaminase inhibitor. Cladribine functions as an inhibitor of DNA synthesis to block the repair of the damaged DNA. Cladribine can inhibit DNA methylation. Cladribine has anti-lymphoma activity. Cladribine can be used for the research of several hematologic malignancies and multiple sclerosis.